trial · primary record
VIS954
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 75 |
| Primary completion | 2029-11-20 |
| Primary endpoint | Proportion of Participants in Remission at Week 24 |
| Registry ID | NCT07904806 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:50.703Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07904806
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.